Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin-Inhibitor-Free de-novo Immunosuppression After Liver Transplantation
2008-008754-23Phase 2Terminated
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of everolimus in hepatorenal syndrome (HRS), chronic kidney disease (CKD) and hepatic disease, sponsored by Universitätsmedizin Göttingen. Primary endpoint: Time-point of biopsy. Started Feb 2009; status: terminated.
02
Drugs
everolimus
03
Conditions
hepatorenal syndrome (HRS)chronic kidney disease (CKD)hepatic disease
Beyond the preview
Go deeper on 2008-008754-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008754-23.